• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与胎龄呈负相关的前体表面活性蛋白 B 的胎儿和新生儿样本。

Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age.

机构信息

Department of Neonatology, Charité University Medical Center, Berlin, Germany.

出版信息

BMC Pediatr. 2013 Oct 10;13:164. doi: 10.1186/1471-2431-13-164.

DOI:10.1186/1471-2431-13-164
PMID:24112641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3852371/
Abstract

BACKGROUND

Alveolar-capillary membrane leaks can increase the amount of surfactant protein B (SP-B) in the bloodstream. The purpose of this study was to measure the concentration of C-proSP-B, a SP-B precursor that includes C-terminal domains, in various body fluids of newborn infants and determine its dependence on gestational age.

METHODS

C-pro-SPB was measured in amniotic fluid and umbilical cord blood at birth, and in peripheral blood and urine on postnatal day 3 in 137 newborn infants with a median birth weight of 2015 g (range, 550-4475 g) and gestational age of 34 weeks (range, 23-42 weeks).

RESULTS

C-proSP-B levels differed more than 100-fold among samples. The levels (median; interquartile range) were highest in peripheral blood (655.6 ng/mL; 419.0-1467.0 ng/mL) and lowest in urine (3.08 ng/mL; 2.96-3.35 ng/mL). C-proSP-B levels in amniotic fluid (314.9 ng/mL; 192.7-603.6 ng/mL) were approximately half of those in peripheral blood. In cord blood C-proSP-B was slightly lower (589.1 ng/mL; 181.2-1129.0 ng/mL) compared with peripheral blood. C-proSP-B levels significantly increased in all the fluids sampled except urine with decreasing gestational age (p < 0.001).

CONCLUSIONS

This novel assay allows for the quantitative measurement of C-proSP-B in blood and amniotic fluid. The dependence of C-proSP-B on gestational age may hamper its use for the detection of alveolar leaks in preterm newborns.

摘要

背景

肺泡-毛细血管膜渗漏会增加血液中表面活性蛋白 B(SP-B)的量。本研究旨在测量各种新生儿体液中的 C 端前体 SP-B(包括 C 端结构域)的浓度,并确定其对胎龄的依赖性。

方法

对 137 例中位出生体重为 2015g(范围 550-4475g)、胎龄为 34 周(范围 23-42 周)的新生儿,在出生时测量羊水和脐血中的 C-proSP-B,并在生后第 3 天测量外周血和尿液中的 C-proSP-B。

结果

样本间 C-proSP-B 水平差异超过 100 倍。外周血中的水平(中位数;四分位距)最高(655.6ng/ml;419.0-1467.0ng/ml),尿液中最低(3.08ng/ml;2.96-3.35ng/ml)。羊水(314.9ng/ml;192.7-603.6ng/ml)中的 C-proSP-B 水平约为外周血的一半。脐血中的 C-proSP-B 略低于外周血(589.1ng/ml;181.2-1129.0ng/ml)。除尿液外,所有采样液中的 C-proSP-B 水平均随着胎龄的降低而显著增加(p<0.001)。

结论

该新方法可定量测定血液和羊水的 C-proSP-B。C-proSP-B 对胎龄的依赖性可能会阻碍其在早产儿肺泡渗漏检测中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3a/3852371/fe1d6d87d687/1471-2431-13-164-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3a/3852371/cc64884b8206/1471-2431-13-164-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3a/3852371/fe1d6d87d687/1471-2431-13-164-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3a/3852371/cc64884b8206/1471-2431-13-164-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3a/3852371/fe1d6d87d687/1471-2431-13-164-2.jpg

相似文献

1
Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age.与胎龄呈负相关的前体表面活性蛋白 B 的胎儿和新生儿样本。
BMC Pediatr. 2013 Oct 10;13:164. doi: 10.1186/1471-2431-13-164.
2
Factors influencing pulmonary surfactant protein A levels in cord blood, maternal blood and amniotic fluid.
Biol Neonate. 1999;75(2):104-10. doi: 10.1159/000014085.
3
The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: the effect of gestational age, fetal gender, and intrauterine infection.胎儿、母体及羊水腔室中的天然白细胞介素-1受体拮抗剂:胎龄、胎儿性别及宫内感染的影响。
Am J Obstet Gynecol. 1994 Oct;171(4):912-21. doi: 10.1016/s0002-9378(94)70058-3.
4
Determination of the pulmonary surfactant-associated protein SP-B in amniotic fluid with a competition ELISA.
Gynecol Obstet Invest. 1994;38(1):24-7. doi: 10.1159/000292439.
5
Amniotic fluid concentration of surfactant proteins in intra-amniotic infection.羊膜腔内感染时羊水表面活性物质蛋白的浓度
J Matern Fetal Neonatal Med. 2008 Sep;21(9):663-70. doi: 10.1080/14767050802215664.
6
[Concentration of procalcitonin in maternal blood, amniotic fluid and in umbilical cord blood as an indicator of neonatal infection].[母体血液、羊水及脐带血中降钙素原浓度作为新生儿感染指标的研究]
Med Wieku Rozwoj. 2006 Oct-Dec;10(4):1043-53.
7
Postnatal changes of leptin levels in full-term and preterm neonates: their relation to intrauterine growth, gender and testosterone.足月儿和早产儿出生后瘦素水平的变化:其与宫内生长、性别和睾酮的关系。
Biol Neonate. 1999 Mar;75(3):167-76. doi: 10.1159/000014093.
8
Prediction of respiratory distress syndrome by the level of pulmonary surfactant protein A in cord blood sera.
Biol Neonate. 2000 Feb;77(2):83-7. doi: 10.1159/000014198.
9
Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants.足月和早产儿脐带血中血管活性肽的稳定前体片段。
Horm Res Paediatr. 2011;76(4):234-9. doi: 10.1159/000329285. Epub 2011 Sep 2.
10
Amniotic fluid heat shock protein 70 concentration in histologic chorioamnionitis, term and preterm parturition.组织学绒毛膜羊膜炎、足月和早产时羊水热休克蛋白70浓度
J Matern Fetal Neonatal Med. 2008 Jul;21(7):449-61. doi: 10.1080/14767050802054550.

引用本文的文献

1
Approaches to Evaluate Lung Inflammation in Translational Research.转化研究中评估肺部炎症的方法。
Vet Pathol. 2018 Jan;55(1):42-52. doi: 10.1177/0300985817726117. Epub 2017 Aug 16.

本文引用的文献

1
Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.晚期表面活性剂替代治疗增加表面活性蛋白-B 含量:一项随机试点研究。
Pediatr Res. 2012 Dec;72(6):613-9. doi: 10.1038/pr.2012.136. Epub 2012 Oct 4.
2
Lipid-protein interactions alter line tensions and domain size distributions in lung surfactant monolayers.脂质-蛋白相互作用改变肺表面活性剂单层的线张力和畴尺寸分布。
Biophys J. 2012 Jan 4;102(1):56-65. doi: 10.1016/j.bpj.2011.11.4007. Epub 2012 Jan 3.
3
Current methods of non-invasive ventilatory support for neonates.
目前用于新生儿的无创通气支持方法。
Paediatr Respir Rev. 2011 Sep;12(3):196-205. doi: 10.1016/j.prrv.2010.12.001. Epub 2011 Jan 21.
4
Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study.表面活性蛋白 B 和 RAGE 在体外循环期间增加:一项初步研究。
Eur Respir J. 2011 Apr;37(4):841-7. doi: 10.1183/09031936.00045910. Epub 2010 Jul 22.
5
Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.循环血浆表面活性蛋白B作为慢性心力衰竭中肺泡-毛细血管屏障损伤的生物标志物。
Circ Heart Fail. 2009 May;2(3):175-80. doi: 10.1161/CIRCHEARTFAILURE.108.819607. Epub 2009 Mar 30.
6
Pulmonary surfactant protein B in the peripheral circulation and functional impairment in patients with chronic heart failure.
Rev Esp Cardiol. 2009 Feb;62(2):136-42. doi: 10.1016/s1885-5857(09)71531-2.
7
Optimal ventilatory strategies and surfactant to protect the preterm lungs.优化通气策略及使用表面活性剂以保护早产儿肺部。
Neonatology. 2008;93(4):302-8. doi: 10.1159/000121456. Epub 2008 Jun 5.
8
Identification of a segment in the precursor of pulmonary surfactant protein SP-B, potentially involved in pH-dependent membrane assembly of the protein.肺表面活性物质蛋白SP-B前体中一个片段的鉴定,该片段可能参与该蛋白的pH依赖性膜组装。
Biochim Biophys Acta. 2007 May;1768(5):1059-69. doi: 10.1016/j.bbamem.2007.01.010. Epub 2007 Jan 24.
9
Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases.肺表面活性物质蛋白A和D:肺部疾病的固有免疫功能及生物标志物
Curr Pharm Des. 2006;12(5):589-598. doi: 10.2174/138161206775474387.
10
Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction.
Clin Exp Pharmacol Physiol. 2005 Aug;32(8):622-7. doi: 10.1111/j.0305-1870.2005.04241.x.